We have located links that may give you full text access.
Application of Artificial Neural Network (ANN) as a predictive tool for the removal of pharmaceutical from wastewater streams using biochar: a multifunctional technology for environment sustainability.
This study investigates biochar as an attractive option for removing pharmaceuticals from wastewater streams utilizing data from various literature sources and also explores the sensitivity of the characteristics and implementation of biochar. ANN 1 was designed to determine the optimal biochar characteristics (Surface Area, Pore Volume) to achieve the maximum percentage removal of pharmaceuticals in wastewater streams. ANN 2 was developed to identify the optimal biomass feedstock composition, pyrolysis conditions (temperature and time), and chemical activation (acid or base) to produce the optimal biochar from ANN 1. ANN 3 was developed to investigate the effectiveness of the biochar produced in ANN 1 and 2 in removing dye from water. Biomass feedstock with a high lignin content and high volatile matter at a high pyrolysis temperature, whether using an acid or base, achieves a high mesopore volume and high surface area. The biochar with the highest surface area and mesopore volume achieved the highest removal percentage. Regardless of hydrophobicity conditions, at low dosages (0.2), a high surface area and pore volume are required for a high percent removal. And with a higher dosage, a lower surface area and pore volume is necessary to achieve a high percent removal.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app